Product or service labeling for PO topotecan suggests steering clear of concomitant utilization of P-gp inhibitors; the conversation with IV topotecan could be fewer severe but is still likely of clinical significanceMay possibly exacerbate accumulation of conjugated bile salts during the liver and cause medical indications. If concomitant use is c